Orthofix Sustainability Profile
Orthofix Medical Inc., commonly referred to as Orthofix, is a prominent player in the global medical device industry, headquartered in the United States. Founded in 1980, the company has established itself as a leader in innovative solutions for spinal and orthopaedic conditions, with a strong operational presence across North America, Europe, and Latin America. Orthofix is renowned for its advanced technologies, including its unique bone growth stimulation devices and innovative spinal implants. These products are designed to enhance patient outcomes and streamline surgical procedures, setting Orthofix apart in a competitive market. The company has achieved significant milestones, including numerous regulatory approvals and a robust portfolio of patents, solidifying its position as a trusted provider in the orthopaedic and spine sectors.
DitchCarbon Score
How does Orthofix's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Orthofix's score of 32 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Orthofix's reported carbon emissions
In 2023, Orthofix reported total carbon emissions of approximately 3,363,000 kg CO2e, comprising 669,000 kg CO2e from Scope 1 and 2,964,000 kg CO2e from Scope 2 (market-based). The company has not disclosed any Scope 3 emissions data for this year. In 2022, Orthofix's global emissions were about 2,859,000 kg CO2e, with 871,000 kg CO2e from Scope 1 and 2,118,000 kg CO2e from Scope 2 (market-based), alongside 68,000 kg CO2e from Scope 3. Notably, the US operations in 2022 contributed 1,447,000 kg CO2e from Scope 2 (market-based) and 130,000 kg CO2e from Scope 1. Despite the significant emissions figures, Orthofix has not set specific reduction targets or initiatives, as indicated by the absence of SBTi (Science Based Targets initiative) reduction targets or documented climate pledges. The company’s emissions data is not cascaded from any parent organisation, ensuring that the reported figures are solely from Orthofix Medical Inc. Overall, while Orthofix has made strides in transparency regarding its emissions, the lack of defined reduction strategies highlights an area for potential improvement in its climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 871,000 | 000,000 |
| Scope 2 | 2,118,000 | 0,000,000 |
| Scope 3 | 68,000 | - |
How Carbon Intensive is Orthofix's Industry?
How Carbon Intensive is Orthofix's Location?
Orthofix's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Orthofix has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
